Table 2.
OR (95% CI) | ||
---|---|---|
Default youth model | ||
Intercept | 0.50 (0.43; 0.59)a | |
ADHD diagnosis | 0.93 (0.79; 1.10) | |
Male gender | 0.73 (0.61; 0.86)a | |
Age (centered) | 1.00 (1.00; 1.03) | |
Age (centered)2 | 1.00 (1.00; 1.01) | |
IQ (centered) | 0.99 (0.98; 1.01) | |
N assessments | 1749 | |
Extended youth model | ||
ADHD diagnosis × male gender | – | |
ADHD diagnosis × age (centered) | 1.04 (1.01; 1.07)a | |
Male gender × age (centered) | – | |
N assessments | 1749 | |
Parental youth model | ||
Maternal age (centered) | – | |
Paternal age (centered) | – | |
Maternal education (centered) | 1.05 (1.00; 1.10)a | |
Paternal education (centered) | – | |
Maternal ADHD score above cut-off | – | |
Paternal ADHD score above cut-off | – | |
Maternal overweight | 1.40 (1.14; 1.73)a | |
Paternal overweight | 1.83 (1.41; 2.36)a | |
N assessments | 828 | |
Affected youth medication model | ||
Psychostimulant use | 0.98 (0.76; 1.26) | |
Antipsychotic use | 0.81 (0.49; 1.34) | |
Melatonin use | 0.74 (0.50; 1.07) | |
Psychostimulant use × male gender | – | |
Psychostimulant use × age (centered) | – | |
Antipsychotic use × male gender | – | |
Antipsychotic use × age (centered) | – | |
Melatonin use × male gender | – | |
Melatonin use × age (centered) | – | |
N assessments | 641 |
aSignificant after FDR correction